{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:00:14Z","timestamp":1787731214336,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["R21 CA252869, R01 CA258359, P01 CA100730"],"award-info":[{"award-number":["R21 CA252869, R01 CA258359, P01 CA100730"]}]},{"name":"National Cancer Institute","award":["R21 CA252869, R01 CA258359, P01 CA100730"],"award-info":[{"award-number":["R21 CA252869, R01 CA258359, P01 CA100730"]}]},{"name":"National Cancer Institute","award":["R21 CA252869, R01 CA258359, P01 CA100730"],"award-info":[{"award-number":["R21 CA252869, R01 CA258359, P01 CA100730"]}]},{"name":"National Cancer Institute","award":["R21 CA252869, R01 CA258359, P01 CA100730"],"award-info":[{"award-number":["R21 CA252869, R01 CA258359, P01 CA100730"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20098-3","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:26:57Z","timestamp":1760711217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Viral oncogenes drive biphenotypic lymphoproliferative malignancy in transgenic mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Daniel A.","family":"Rauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancy","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"20098_CR1","doi-asserted-by":"crossref","unstructured":"Poiesz, B. J. et al. Detection and isolation of Type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences 77(12):7415\u20137419. (1980).","DOI":"10.1073\/pnas.77.12.7415"},{"key":"20098_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida, M., Miyoshi, I. & Hinuma, Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in disease. Proc. Natl. Acad. Sci. USA. 79, 2031\u20132035 (1982).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20098_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JOP.2017.021907","volume":"13","author":"N Mehta-Shah","year":"2017","unstructured":"Mehta-Shah, N., Ratner, L. & Horwitz, S. M. Adult T-cell leukemia\/lymphoma. J. Oncol. Pract. 13, 487\u2013492 (2017). PMID:28796955.","journal-title":"J. Oncol. Pract."},{"key":"20098_CR4","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti, F. A., Carneiro-Proietti, A. B. F., Catalan-Soares, B. C. & Murphy, E. L. Global epidemiology of HTLV-I and associated diseases. Oncogene 24, 6058\u20136068 (2005).","journal-title":"Oncogene"},{"key":"20098_CR5","doi-asserted-by":"publisher","first-page":"article388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain, A. & Cassar, O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3, article388 (2012).","journal-title":"Front. Microbiol."},{"key":"20098_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.17980\/2018.45","volume":"4","author":"R Bolanos","year":"2018","unstructured":"Bolanos, R. et al. Decreased levels of the serum inflammatory biomarkers sGP130, IL-6, sCRP, and BAFF are associated with increased likelihood of AIDS-related kaposi\u2019s sarcoma in men who have sex with men. Cancer Res. Fronteiers. 4, 45\u201359 (2018).","journal-title":"Cancer Res. Fronteiers"},{"key":"20098_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/infdis\/jit558","volume":"209","author":"LBM Cook","year":"2014","unstructured":"Cook, L. B. M. & Taylor, G. P. HTLV-1 and HTLV-2 prevalence in the united States. J. Infect. Disease. 209, 486\u2013487 (2014).","journal-title":"J. Infect. Disease"},{"key":"20098_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/bjh.15234","volume":"184","author":"B Malik","year":"2019","unstructured":"Malik, B. & Taylor, G. P. Can we reduce the incidence of adult T-cell leukaemia\/lymphoma? Cost-effectiveness of human T-lymphotropic virus type1 (HTLV-1) antenatal screening in the united Kingdom. Br. J. Haematol. 184, 1040\u20131043 (2019).","journal-title":"Br. J. Haematol."},{"key":"20098_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.coviro.2016.08.009","volume":"20","author":"AR Panfil","year":"2016","unstructured":"Panfil, A. R., Martinez, M. P., Ratner, L. & Green, P. L. Human T-cell leukemia virus-associated malignancy. Curr. Opin. Virol. 20, 40\u201346 (2016). PMID: 27591679.","journal-title":"Curr. Opin. Virol."},{"key":"20098_CR10","unstructured":"World Health Organization. Human T-lymphotropic virus type 1: technical report. In. Edited by IGO LCB-N-S; (2020)."},{"key":"20098_CR11","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/sj.onc.1206551","volume":"22","author":"M Matsuoka","year":"2003","unstructured":"Matsuoka, M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22, 5131\u20135140 (2003).","journal-title":"Oncogene"},{"key":"20098_CR12","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1038\/sj.onc.1208977","volume":"24","author":"C Nicot","year":"2005","unstructured":"Nicot, C., Harrod, R. L., Ciminale, V. & Franchini, G. Human T-cell leukemia\/lymphoma type 1 nonstructural genes and their functions. Oncogene 24, 6026\u20136034 (2005).","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"20098_CR13","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1097\/00042560-199600001-00025","volume":"13","author":"W Grossman","year":"1996","unstructured":"Grossman, W. & Ratner, L. Transgenic mouse models for HTLV-1 infection. J. Acquir. Immune Defic. Syndrome Hum. Retroviruses. 13 (Suppl 1), S162\u2013S169 (1996). PMID:8797719.","journal-title":"J. Acquir. Immune Defic. Syndrome Hum. Retroviruses"},{"key":"20098_CR14","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou, Y. et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 7, e1001274 (2011).","journal-title":"PLoS Pathog."},{"key":"20098_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.coviro.2017.07.013","volume":"26","author":"L Cook","year":"2017","unstructured":"Cook, L., Melamed, A., Yaguchi, H. & Bangham, C. R. The impact of HTLV-1 on the cellular genome. Curr. Opin. Virol. 26, 125\u2013131 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"20098_CR16","doi-asserted-by":"publisher","first-page":"e1002025","DOI":"10.1371\/journal.ppat.1002025","volume":"7","author":"H Zhi","year":"2011","unstructured":"Zhi, H. et al. NF-kappaB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein Hbz. PLoS Pathog. 7, e1002025 (2011).","journal-title":"PLoS Pathog."},{"key":"20098_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fmicb.2018.00285","volume":"9","author":"S Fochi","year":"2018","unstructured":"Fochi, S., Mufascio, S., Bertazzoni, U., Zipeto, D. & Romanelli, M. G. HTLV deregulation of the NF-kB pathway: an update on tax and antisense proteins role. Front. Microbiol. 9, 285 (2018).","journal-title":"Front. Microbiol."},{"key":"20098_CR18","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1038\/onc.2012.450","volume":"32","author":"G Ma","year":"2013","unstructured":"Ma, G., Yasunaga, J., Fan, J., Yanagawa, S. & Matsuoka, M. HTLV-1 bZIP factor dysregualtes the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene 32, 4222\u20134230 (2013).","journal-title":"Oncogene"},{"key":"20098_CR19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","volume":"118","author":"T Zhao","year":"2011","unstructured":"Zhao, T. et al. HTLV-1 bZIP factor enhances TGF-beta signalling through p300 coactivator. Blood 118, 1865\u20131876 (2011).","journal-title":"Blood"},{"key":"20098_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.onc.1208297","volume":"24","author":"J Matsumoto","year":"2005","unstructured":"Matsumoto, J., Oshima, T., Isono, O. & Shimotohno, K. Hbz suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 24, 1001\u20131010 (2005).","journal-title":"Oncogene"},{"key":"20098_CR21","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","volume":"8","author":"H Gazon","year":"2017","unstructured":"Gazon, H., Barbeau, B., Mesnard, J. M. & Peloponese, M. M. Hijacking of the AP-1 signaling pathway during development of ATL. Front. Microbiol. 8, 2686 (2017).","journal-title":"Front. Microbiol."},{"key":"20098_CR22","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1158\/0008-5472.CAN-15-0942","volume":"75","author":"Y Mitobe","year":"2015","unstructured":"Mitobe, Y., Yasunaga, J., Furuta, R. & Matsuoka, M. HTLV-1 bZIP factor RNA and protein impart distinct functions on T-cell proliferation and survival. Cancer Res. 75, 4143\u20134152 (2015).","journal-title":"Cancer Res."},{"key":"20098_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham, C. R. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 39, 1700\u20131712 (2009).","journal-title":"Eur. J. Immunol."},{"key":"20098_CR24","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","volume":"88","author":"S Tamiya","year":"1996","unstructured":"Tamiya, S. et al. Two types of defective human T-lymphotropic virus I provirus in adult T-cell leukemia. Blood 88, 3065\u20133073 (1996).","journal-title":"Blood"},{"key":"20098_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/v8060171","volume":"8","author":"P Miyazato","year":"2016","unstructured":"Miyazato, P., Matsuo, M., Katsuya, H. & Satou, S. Transcriptional and epigenetic regualtory mechanisms affecting HTLV-1 provirus. Viruses 8, 171 (2016).","journal-title":"Viruses"},{"key":"20098_CR26","doi-asserted-by":"crossref","unstructured":"Mahgoub, M. et al. Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells. Proceedings of the National Academy of Sciences, USA 115:E1269-E1278. (2018).","DOI":"10.1073\/pnas.1715724115"},{"key":"20098_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3960\/jslrt.56.119","volume":"56","author":"R Kawano","year":"2016","unstructured":"Kawano, R., Niino, D. & Ohshima, K. Six case of CD20-positive adult T-cell leukemia. J. Clin. Experimental Hematopathology. 56, 119\u2013125 (2016).","journal-title":"J. Clin. Experimental Hematopathology"},{"key":"20098_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00011-022-01622-x","volume":"71","author":"AYS Lee","year":"2022","unstructured":"Lee, A. Y. S. CD20\u2009+\u2009T cells: an emerging T cell subset in human pathology. Inflamm. Res. 71, 1181\u20131189 (2022).","journal-title":"Inflamm. Res."},{"key":"20098_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/cyto.10131","volume":"50","author":"DW Kingma","year":"2002","unstructured":"Kingma, D. W. et al. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms. Cytometry 50, 243\u2013248 (2002).","journal-title":"Cytometry"},{"key":"20098_CR30","first-page":"263","volume":"37","author":"CL Buckner","year":"2007","unstructured":"Buckner, C. L., Christiansen, L. R., Bourgeois, D., Lazarchick, J. J. & Lazarchick, J. CD20 positive T-cell lymphoma\/leukemia: a rare entity with potential diagnostic pitfalls. Ann. Clin. Lab. Sci. 37, 263\u2013267 (2007).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"20098_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/leu.2013.354","volume":"28","author":"L Slamova","year":"2014","unstructured":"Slamova, L. et al. CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage. Leukemia 28, 609\u2013620 (2014).","journal-title":"Leukemia"},{"key":"20098_CR32","doi-asserted-by":"crossref","unstructured":"Grossman, W. J. et al. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proceedings of the National Academy of Sciences 92:1057\u20131061. PMCID:PMC42636. (1995).","DOI":"10.1073\/pnas.92.4.1057"},{"key":"20098_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nm1389","volume":"12","author":"H Hasegawa","year":"2006","unstructured":"Hasegawa, H. et al. Thymus-derived leukemia-lymphoma in mice Transgenic for the tax gene of human T-lymphotropic virus type I. Nat. Med. 12, 466\u2013472 (2006).","journal-title":"Nat. Med."},{"key":"20098_CR34","doi-asserted-by":"publisher","first-page":"35713","DOI":"10.1074\/jbc.M504848200","volume":"280","author":"H Kwon","year":"2005","unstructured":"Kwon, H. et al. Lethal cutaneous disease in Transgenic mice conditionally expressing type I human T cell leukemia virus tax. J. Biol. Chem. 280, 35713\u201335722 (2005).","journal-title":"J. Biol. Chem."},{"key":"20098_CR35","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2008-08-174425","volume":"114","author":"J Yamazaki","year":"2009","unstructured":"Yamazaki, J. et al. Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia\/lymphoma. Blood 114, 2709\u20132720 (2009).","journal-title":"Blood"},{"key":"20098_CR36","doi-asserted-by":"publisher","first-page":"69250","DOI":"10.18632\/oncotarget.20565","volume":"27","author":"AK Esser","year":"2017","unstructured":"Esser, A. K. et al. HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget 27, 69250\u201369263 (2017).","journal-title":"Oncotarget"},{"key":"20098_CR37","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1182\/blood-2005-04-1730","volume":"106","author":"L Gao","year":"2005","unstructured":"Gao, L. et al. HTLV-1 tax Transgenic mice develop spontaneous osteolytic bone disease prevented by osteoclast inhibiton. Blood 106, 4294\u20134302 (2005). PMCID:PMC1895233.","journal-title":"Blood"},{"key":"20098_CR38","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1182\/blood-2008-07-166462","volume":"113","author":"D Rauch","year":"2009","unstructured":"Rauch, D. et al. Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood 113, 1493\u20131500 (2009). PMCID:PMC2644076.","journal-title":"Blood"},{"key":"20098_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nm.1886","volume":"15","author":"S Gross","year":"2009","unstructured":"Gross, S. et al. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 15, 455\u2013461 (2009). PMID: 18971418 PMCID: PMC12644076.","journal-title":"Nat. Med."},{"issue":"Suppl 1","key":"20098_CR40","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1186\/1742-4690-8-S1-A4","volume":"8","author":"D Rauch","year":"2011","unstructured":"Rauch, D., Bokhari, S., Harding, J. & Ratner, L. Tet-inducible lymphoma in a new tax Transgenic mouse model. Retrovirology 8 (Suppl 1), A4 (2011). PMID: 20017942.","journal-title":"Retrovirology"},{"key":"20098_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.1092436","volume":"303","author":"T Tumbar","year":"2004","unstructured":"Tumbar, T. et al. Defining the epithelial stem cell niche in skin. Science 303, 359\u2013363 (2004).","journal-title":"Science"},{"key":"20098_CR42","doi-asserted-by":"publisher","first-page":"19852","DOI":"10.1038\/srep19852","volume":"6","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. Tcstv1 and Tcstv3 elongate telomeres of mouse ES cells. Sci. Rep. 6, 19852 (2016).","journal-title":"Sci. Rep."},{"key":"20098_CR43","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"20098_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"20098_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gene.2004.01.010","volume":"330","author":"M Agren","year":"2004","unstructured":"Agren, M., Kogerman, P., Kleman, M., Wessling, M. & Toftgard, R. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene 330, 101\u2013114 (2004).","journal-title":"Gene"},{"key":"20098_CR46","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1038\/s41598-019-47382-3","volume":"9","author":"D Xiong","year":"2019","unstructured":"Xiong, D., Wang, Y. & You, M. Tumor intrinsic immunity related proteins May be novel tumor suppressors in some types of cancer. Sci. Rep. 9, 10918 (2019).","journal-title":"Sci. Rep."},{"key":"20098_CR47","doi-asserted-by":"publisher","first-page":"24426","DOI":"10.1074\/jbc.M802316200","volume":"283","author":"AK Munirajan","year":"2008","unstructured":"Munirajan, A. K. et al. KIF1Bbeta functions as a haploinsufficient tumor suppresor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J. Biol. Chem. 283, 24426\u201324434 (2008).","journal-title":"J. Biol. Chem."},{"key":"20098_CR48","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/jid.2012.506","volume":"133","author":"SX Atwood","year":"2013","unstructured":"Atwood, S. X. & Whitson, R. J. Oro aE: patching up our tumor signaling knowledge. J. Invest. Dermatology. 133, 1131\u20131133 (2013).","journal-title":"J. Invest. Dermatology"},{"key":"20098_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/09168451.2014.991686","volume":"79","author":"BTT Nga","year":"2015","unstructured":"Nga, B. T. T., Luziga, C., Yamamoto, M., Kusakabe, T. & Yamamoto, Y. Identification and characterization of the interactive proteins with cytotoxic T-lymphocyte antigen-2alpha. Biosocience Biotechnol. Biochem. 79, 587\u2013597 (2015).","journal-title":"Biosocience Biotechnol. Biochem."},{"key":"20098_CR50","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cellsig.2011.05.014","volume":"23","author":"L Zhang","year":"2011","unstructured":"Zhang, L. et al. Cytotoxic T lymphocyte antigen-2alpha induces apoptosis of murine T-lymphoma cels and cardiac fibroblasts and is regulated by cAMP\/PKA. Cell. Signal. 23, 1611\u20131616 (2011).","journal-title":"Cell. Signal."},{"key":"20098_CR51","unstructured":"Bangham, C. R. M. & Matsuoka, M. Human T-cell leukemia virus types 1 and 2. in Fields Virology. Volume RNA Viruses, edn. (eds Howley, P. M. et al.) 527\u2013557 (Lippincott Williams & Wilkins, Philadelphia, PA, 2023)."},{"key":"20098_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12688\/wellcomeopenres.12469.2","volume":"2","author":"MR Billman","year":"2017","unstructured":"Billman, M. R., Rueda, D. & Bangham, C. R. M. Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1. Welcome Open. Res. 2, 87 (2017).","journal-title":"Welcome Open. Res."},{"key":"20098_CR53","doi-asserted-by":"publisher","first-page":"e1005120","DOI":"10.1371\/journal.ppat.1005120","volume":"11","author":"Y Mitgami","year":"2015","unstructured":"Mitgami, Y., Ysaunaga, J., Kinosada, H., Ohshima, K. & Matsuoka, M. Interferon-gamma promotes inlammation and development of T-cell lymphoma in HTLV-1 bZIP factor Transgenic mice. PLoS Pathog. 11, e1005120 (2015).","journal-title":"PLoS Pathog."},{"key":"20098_CR54","doi-asserted-by":"publisher","first-page":"8731","DOI":"10.3390\/ijms24108731","volume":"24","author":"M Nakashima","year":"2023","unstructured":"Nakashima, M. & Uchimaru, K. CD30 expression and its function during the disease progression of adult T-cell leukemia\/lymphoma. Int. J. Mol. Sci. 24, 8731 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"20098_CR55","doi-asserted-by":"crossref","unstructured":"ShahUA et al. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood 132, 1507\u20131518 (2018).","DOI":"10.1182\/blood-2018-01-824607"},{"key":"20098_CR56","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cancers14102394","volume":"14","author":"S Sakihama","year":"2022","unstructured":"Sakihama, S. & Kaube, K. Genetic alterations in adult T-cell leukemia\/lymphoma: novel discoveries with clinical and biological significance. Cancers 14, 2394 (2022).","journal-title":"Cancers"},{"key":"20098_CR57","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.bbamcr.2013.03.006","volume":"1833","author":"C Ishikawa","year":"2013","unstructured":"Ishikawa, C., Kawakami, H., Uchihara, J-N., Senba, M. & Mori, N. CD69 overexpression by human T-cell leukemia virus type 1 tax transactivation. Biochim. Biophys. Acta. 1833, 1542\u20131552 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"20098_CR58","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1128\/JVI.73.5.3709-3717.1999","volume":"73","author":"R Weil","year":"1999","unstructured":"Weil, R. et al. Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines. J. Virol. 73, 3709\u20133717 (1999).","journal-title":"J. Virol."},{"key":"20098_CR59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.devcel.2016.04.011","volume":"37","author":"AM Daulat","year":"2016","unstructured":"Daulat, A. M. et al. PRICKLE1 contribute to cancer cell dissemination through its interaction with mTORC2. Dev. Cell. 37, 311\u2013325 (2016).","journal-title":"Dev. Cell"},{"key":"20098_CR60","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.3390\/cancers16213699","volume":"16","author":"B Patel","year":"2024","unstructured":"Patel, B. et al. Deciphering CD59: unveiling its role in immune microenvironment and prognostic significance. Cancers 16, 3699 (2024).","journal-title":"Cancers"},{"key":"20098_CR61","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.4049\/jimmunol.155.9.4376","volume":"155","author":"GT Spear","year":"1995","unstructured":"Spear, G. T. et al. Host cell-derived complement control proteins CD55 and CD59 are incorporated into virions of two unrelated enveloped viruses. J. Immunol. 155, 4376\u20134381 (1995).","journal-title":"J. Immunol."},{"key":"20098_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ydbio.2004.05.018","volume":"272","author":"F Zeng","year":"2004","unstructured":"Zeng, F., Baldwin, D. A. & Schultz, R. M. Transcript profiling during preimplantation mouse development. Dev. Biol. 272, 483\u2013496 (2004).","journal-title":"Dev. Biol."},{"key":"20098_CR63","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1093\/nar\/gkl631","volume":"34","author":"W Zhang","year":"2006","unstructured":"Zhang, W. et al. Zfp206 regulates ES cell gene expression and differentiation. Nucleic Acids Res. 34, 4780\u20134790 (2006).","journal-title":"Nucleic Acids Res."},{"key":"20098_CR64","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.5045\/br.2022.2022037","volume":"57S1","author":"J Cho","year":"2022","unstructured":"Cho, J. Basic immunohistochemistry for lymphoma diagnosis. Blood Res. 57S1, S55\u2013S61 (2022).","journal-title":"Blood Res."},{"key":"20098_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3960\/jslrt.56.119","volume":"56","author":"R Kawano","year":"2016","unstructured":"Kawano, R., Niino, D. & Ohshima, K. Six cases of CD20-positive adult T-cell leukemia. J. Clin. Experimental Hematopathology. 56, 119\u2013125 (2016).","journal-title":"J. Clin. Experimental Hematopathology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20098-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:03:33Z","timestamp":1760713413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20098"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20098-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed in accordance with research protocols approved by the division of comparative medicine and the Institutional Animal Care and Use Committee (IACUC) at Washington University in Saint Louis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36325"}}